Development of acute lymphoblastic leukemia with translocation (4;11) in a young girl with familial pericentric inversion 12

Cancer Genet Cytogenet. 1999 Apr 15;110(2):124-7. doi: 10.1016/s0165-4608(98)00203-9.

Abstract

We report a case of a 1-year-old girl with familial pericentric inv(12) who developed acute lymphoblastic leukemia (ALL) with t(4;11) 1 month after recovery from idiopathic hemophagocytic lymphohistiocytosis (HLH). The inv(12)(p13q15) was first found in bone marrow (BM) cells when she was diagnosed as having HLH, and then detected in the BM blasts together with t(4;11)(q21;q23) when she developed ALL. The inv(12) was retained in the BM cells after she achieved complete remission. Cytogenetic analysis on the PHA-stimulated peripheral lymphocytes revealed inv(12) in all of the 30 cells examined. Because the data that ALL with t(4;11) predicts an extremely poor prognosis, she received an allogeneic BM transplantation from an HLA-matched sibling at 10 months from the onset of ALL. She is now at 26 months post transplantation and maintains in a state of complete remission. Familial cytogenetic study demonstrated that 4 of 8 maternal members examined had the inv(12), but they showed no family history of a higher risk of development of hematological and other types of malignancies, suggesting that pericentric inv(12) itself might not be directly involved in the development of ALL in this case.

Publication types

  • Case Reports

MeSH terms

  • Bone Marrow / physiology
  • Bone Marrow Transplantation
  • Chromosome Inversion*
  • Chromosomes, Human, Pair 11
  • Chromosomes, Human, Pair 12*
  • Chromosomes, Human, Pair 4
  • Female
  • Gene Rearrangement
  • Histiocytosis, Non-Langerhans-Cell / genetics
  • Humans
  • Infant
  • Karyotyping
  • Lymphocytes / drug effects
  • Lymphocytes / physiology
  • Male
  • Pedigree
  • Phytohemagglutinins / pharmacology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Translocation, Genetic*

Substances

  • Phytohemagglutinins